EVI2B and osteosarcoma: An immune-stromal score-based gene signature containing FPR1, GBP1, FUCA1, PDK1, BNIP3, EVI2B, APBB1IP, FOLR2, and COCH was established for predicting clinical outcomes of osteosarcoma subjects.